July 31, 2018 / 8:39 AM / 21 days ago

BRIEF-MerLion Regains North American Rights to XTORO

July 31 (Reuters) - Novartis AG:

* MERLION PHARMACEUTICALS- NOVARTIS HAS MADE A PORTFOLIO DECISION AND TERMINATED LICENSE BETWEEN ALCON AND MERLION EXECUTED IN 2010

* MERLION PHARMACEUTICALS- MERLION NOW OWNS ALL RIGHTS TO XTORO GLOBALLY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below